Contact
Please use this form to send email to PR contact of this press release:
YMAB INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Investors in Y-mAbs Therapeutics (YMAB) With Significant Losses to Contact the Firm’s Attorneys, Firm Investigating Possible Securities Law Violations
TO: